Andere talen Sansure Biotech Inc.

Aandelen

688289

CNE1000043J1

slotkoers Shanghai S.E. Andere beurzen 00:00:00 30-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
20,46 ^CNY	+1,49%		+11,62%	+4,65%

26/04	Sansure Biotech Inc. Rapporteert winstresultaten voor het eerste kwartaal dat eindigde op 31 maart 2024	CI
29/02	De winst van Sansure Biotech in 2023 daalt met 81% terwijl de inkomsten met 84% dalen	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Sansure Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	26/04
Sansure Biotech's 2023 Profit Drops 81% as Revenue Slumps 84%	29/02
Sansure Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/02
ASEP Medical Holdings Signs JV Agreement with Chinese Medical Diagnostics Co Sansure Biotech Inc.	22/11
Sansure Biotech Secures EU Certification For In Vitro Diagnostic Device	15/11
Sansure Biotech Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023	30-10-23
Tranche Update on Sansure Biotech Inc.'s Equity Buyback Plan announced on October 21, 2022.	11-10-23
Sansure Biotech Inc.'s Equity Buyback announced on October 21, 2022, has closed with 9,865,793 shares, representing 1.7% for CNY 200 million.	09-10-23
Sansure Biotech Gets EU CE certification for 60 products	22-09-23
Certain A Shares of Sansure Biotech Inc. are subject to a Lock-Up Agreement Ending on 28-AUG-2023.	28-08-23
Sansure Biotech Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	16-08-23
Sansure Biotech's Human Papillomavirus Kit Gets EU Registration Certificate	27-07-23
Tranche Update on Sansure Biotech Inc.'s Equity Buyback Plan announced on October 21, 2022.	01-07-23
Sansure Biotech Inc.(SHSE:688289) dropped from Shanghai Stock Exchange Health Care Sector Index	09-06-23
Sansure Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	25-04-23
Tranche Update on Sansure Biotech Inc.'s Equity Buyback Plan announced on October 21, 2022.	05-04-23
Sansure Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	27-02-23
Asep Inc. Lower After Signing JV Term Sheet with Leading Chinese Medical Diagnostic Co. Sansure Biotech Inc.	30-01-23
Sansure Biotech Gets Certification for COVID-19 Kit	30-01-23
ASEP Medical Holdings Inc. Signs Joint Venture Term Sheet with Sansure Biotech Inc. in Preparation for the Commercialization of the Sepset(ER) Sepsis Diagnostic Test in China	28-01-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Sansure Biotech Inc.

Aandelen

688289

CNE1000043J1

Andere talen

Filters